The extent to which demographics of participants enrolled in cannabis clinical trials are representative of those who use cannabis is unknown. A new study published in Nature: Scientific Reports compared 2002 to 2021 data from the National Survey on Drug Use and Health (NSDUH) on “past-month” cannabis use across various population subgroups with participant demographics were extracted from peer-reviewed clinical trials reporting on pharmacokinetic and/or pharmacodynamic models of cannabis or cannabinoids. Results identified that cannabis clinical trial participants are skewed toward overrepresentation by White males in their 20s and 30s.  Read the article here.